Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface
© Herzog et al.; licensee BioMed Central Ltd. 2013
Received: 6 June 2012
Accepted: 17 March 2013
Published: 4 April 2013
Due to its antibacterial properties, silver (Ag) has been used in more consumer products than any other nanomaterial so far. Despite the promising advantages posed by using Ag-nanoparticles (NPs), their interaction with mammalian systems is currently not fully understood. An exposure route via inhalation is of primary concern for humans in an occupational setting. Aim of this study was therefore to investigate the potential adverse effects of aerosolised Ag-NPs using a human epithelial airway barrier model composed of A549, monocyte derived macrophage and dendritic cells cultured in vitro at the air-liquid interface. Cell cultures were exposed to 20 nm citrate-coated Ag-NPs with a deposition of 30 and 278 ng/cm2 respectively and incubated for 4 h and 24 h. To elucidate whether any effects of Ag-NPs are due to ionic effects, Ag-Nitrate (AgNO3) solutions were aerosolised at the same molecular mass concentrations.
Agglomerates of Ag-NPs were detected at 24 h post exposure in vesicular structures inside cells but the cellular integrity was not impaired upon Ag-NP exposures. Minimal cytotoxicity, by measuring the release of lactate dehydrogenase, could only be detected following a higher concentrated AgNO3-solution. A release of pro-inflammatory markers TNF-α and IL-8 was neither observed upon Ag-NP and AgNO3 exposures as well as was not affected when cells were pre-stimulated with lipopolysaccharide (LPS). Also, an induction of mRNA expression of TNF-α and IL-8, could only be observed for the highest AgNO3 concentration alone or even significantly increased when pre-stimulated with LPS after 4 h. However, this effect disappeared after 24 h. Furthermore, oxidative stress markers (HMOX-1, SOD-1) were expressed after 4 h in a concentration dependent manner following AgNO3 exposures only.
With an experimental setup reflecting physiological exposure conditions in the human lung more realistic, the present study indicates that Ag-NPs do not cause adverse effects and cells were only sensitive to high Ag-ion concentrations. Chronic exposure scenarios however, are needed to reveal further insight into the fate of Ag-NPs after deposition and cell interactions.
Nanotechnology is a rapidly growing field, with the application of engineered nanomaterials in daily life constantly increasing. Nanoparticles (NPs) are defined by the European Commission as materials whose main constitutes have three dimension between 1 and 100 billionth of a metre . Numerous different types of NPs, have been engineered for use in a wide array of consumer, industrial and technological applications due to their high surface to volume ratio that leads to unique physical and chemical properties. As a result of their widespread applications therefore, a significant increase of commercial nanotechnology industry is presumed within the next years . So far, silver nanoparticles (Ag-NPs) have been used in more consumer products than any other nanomaterial , mainly due to its antimicrobial properties [4, 5]. The use of Ag as an antimicrobial agent however, is not a new concept as it has been used for example since the 17th century as an essential multipurpose medicinal product . Examples of recent consumer applications using Ag as antimicrobial agents consist of: food supplements, materials for food packaging, coatings on medical devices, water disinfectants, air filters, electronic appliances, odour-resistant textile fabrics and cosmetic products, such as deodorants [7, 8].
Despite the promising advantages posed by using Ag-NPs in such applications, the possible health effects associated with the inevitable human exposure to NPs [9, 10] has raised concerns as to the mass use and production of Ag-NPs without having a clear understanding of their specific interaction with biological systems . Therefore, increased attention has been given to the potential human health and environmental effects following Ag-NP exposure . In regards to the human interaction with Ag-NPs, numerous different exposure routes exist: via the lung, skin, bloodstream and ingestion. It is assumed, however, that inhalation of Ag-NPs is of primary concern for humans in an occupational setting .
It has been shown that following in vitro exposures of Ag-NPs to various different cell types in particular immune cells such as macrophages and monocytes [14–16] and epithelial lung cells [17–19] that these NPs can induce significant cytotoxicity and (pro)-inflammatory cytokine release as well as induce increased levels of oxidative stress and reactive oxygen species (ROS) production over acute time periods (≤48 hours) [17, 20, 21]. Furthermore, investigation into the potential genotoxicity of Ag-NPs has also shown that these NPs can cause significant DNA damage in human lung cells in vitro [20, 22]. Despite this, a clear understanding of the specific Ag-NP cell-interaction is severely limited. This is highlighted by the disparity whether the just described effects of Ag-NPs are in fact a direct result of the NPs themselves, or rather due to the interaction with Ag-ions [23, 24] that are released when Ag-NPs are placed into solution . In the presence of moisture, metallic Ag-NPs oxidize, which results in the release of Ag-ions. Because Ag oxidation is a slow reaction, the size of Ag NPs is critical to achieve microorganism growth control . Several studies illustrate this contradicting picture and further highlight other aspects that may contribute towards the biological impact of Ag. These include the shape and size [27, 28], NP related ROS production  or a combined mechanism of particle and ion exposure . Due to the contradicting literature and the unknown mechanistic behaviour of Ag toxicity, it is imperative therefore, that increased, in-depth research is performed in order to assess if the potential advantageous properties of Ag-NPs can be realised safely in commercial nanotechnological applications.
There are a number of different experimental approaches described in order to investigate the possible adverse effects of Ag-NPs towards the human lung. Many studies are performed in vitro using cultured lung cells under submerged conditions [31–34]. Such exposures however, do not represent the conditions that would be expected in the human lung when a NP containing aerosol is inhaled. In animals, NPs can be applied via instillation  or by inhalation . Since there are many efforts on-going to use sophisticated in vitro methods for toxicology testing in order to reduce the number of invasive animal-based testing strategies  our research group has established and evaluated an in vitro model of the human epithelial airway barrier composed of epithelial cells and the two most important immune cells of the lung (i.e. macrophages and dendritic cells), to study NP lung-cell interactions and their possible responses . Since this model can be used at the air-liquid interface it allows the direct exposure of cells to an aerosol , thus representing a realistic situation following inhalation of NPs. Recently, a novel dose controlled air-liquid interface cell exposure (ALICE) system for NP aerosols  has been established and has been employed to evaluate the possible adverse effects of zinc oxide  and gold NPs [41, 42]. Therefore, the aim of the present study was to use the same experimental set-up to assess the cytotoxicity, the oxidative potential and pro-inflammatory effects of Ag-NPs in comparison to Ag-ions at the same molecular mass.
Particle exposure and characterisation
Lung cell morphology and intracellular Ag-NP localisation
Effects of Ag-NPs and Ag-ions on cell integrity were assessed by measuring the activity of lactate dehydrogenase (LDH) released into the cell culture medium of the lower trans-well chamber. Potential effects were also measured in cultures incubated with lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNF-α), which was used to study possible aggravation effects of Ag-NPs in response to a pro-inflammatory stimulus and the positive control for interleukine-8 (IL-8) release respectively.
The immune response of the triple cell co-culture system after exposure to Ag-NPs or AgNO3 was measured by quantifying the amount of specifically released pro-inflammatory proteins TNF-α and IL-8 via enzyme-linked immunosorbent assay (ELISA) 4 h and 24 h after exposure. Unexposed cells served as negative control. Moreover, cells were also pre-treated with 1 μg/mL LPS 2 h before exposure to study Ag-NP and Ag-ion effects under inflammatory conditions. As positive control, unexposed cells pre-treated with LPS were used. As a positive control for IL-8 secretion, cells were treated with 15 ng/mL TNF-α.
Similar to TNF-α release, IL-8 concentrations for unexposed cells (4 h: 3.9 ± 1.4 ng/mL; 24 h: 6.8 ± 2.6 ng/mL) increased upon LPS treatment (4 h: 13.8 ± 0.6 ng/mL; 24 h: 15.5 ± 0.7 ng/mL) (Figure 5C). Ag-NP exposure did not significantly change the IL-8 release. Incubation with TNF-α stimulated IL-8 secretion to a lesser extent than LPS but showed a similar pattern (4 h: 6.1 ± 1.2 ng/mL; 24 h: 10.5 ± 2.0 ng/mL). Comparable to Ag-NPs, released IL-8 concentrations after AgNO3 exposures were not significantly different from unexposed cells (4 h: 1.5 ± 0.8 ng/mL; 24 h: 18.4 ± 1.4 ng/mL) and LPS treated un\exposed cells (4 h: 14.9 ± 1.1 ng/mL; 24 h: 18.4 ± 1.4 ng/mL) (Figure 5D). As for Ag-NP experiments, stimulation with TNF-α revealed a similar but lower concentration pattern (4 h: 3.6 ± 1.7 ng/mL; 24 h: 11.0 ± 3.0 ng/mL) compared to LPS stimulation.
Real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) of pro-inflammatory and oxidative stress markers
Similar effects could be observed for TNF-α and IL-8 expression upon 0.22 mM and 2.2 mM AgNO3-exposures (Figure 6B). However, after 22 mM AgNO3 exposure the IL-8 expression was significantly increased after 4 h (7.3 ± 0.6 fold) which could not any more be observed after 24 h. Furthermore, 22 mM AgNO3 exposure following LPS treatment significantly increased IL-8 gene expression after 4 h (198.5 ± 53.8 fold) compared to unexposed LPS treated cells. An elevated change of expression could also be observed for 2.2 mM AgNO3-exposed LPS treated cells after 4 h (57.7 ± 32.1 fold); however, due to high standard deviation this was not significant. Compared to unexposed cells TNF-α expression revealed no statistical differences. In contrast to the Ag-NPs, the AgNO3-exposures showed a concentration dependent effect of HMOX-1 expression after 4 h with a significant difference at the highest concentration of 22 mM AgNO3 (4 h: 27.7 ± 13.8 fold; 4 h LPS: 32.7 ± 12.3 fold), which diminished after 24 h. TNF-α treatment induced IL-8 expression (4 h: 5.1 ± 3.9 fold; 24 h: 2.5 ± 1.3 fold) to a lesser extent compared to LPS treatment. Furthermore, a moderate induction of TNF-α after 24 h could be detected (4.2 ± 1.0 fold).
Since AgNO3 exposures have shown both cytotoxic as well as pro-inflammatory effects at the highest concentration used with the triple cell co-cultures, a select number of experiments were repeated with A549 monocultures to compare the two cell culture systems. For the cytotoxicity assay similar results as for the triple cell co-cultures were obtained for A549 monocultures exposed to AgNO3 even though significant LDH release could only be observed for LPS treated cells (see Additional file 1). Additionally, release of IL-8 in A549 monocultures exposed to AgNO3 could not be detected, even not for LPS treated cells, as A549 do not have a receptor for this endotoxin (see Additional file 2). However, upon stimulation with TNF-α a strong release of IL-8 could be observed.
The aim of the study was to analyse the cytotoxic and pro-inflammatory effects of 20 nm citrate-coated Ag-NPs exposed at the air-liquid interface to an epithelial airway model of the human lung in vitro. The study was designed according to a recent publication with 15 nm citrate-coated gold NPs using the same air-liquid cell exposure system and analysis of the same cellular reaction endpoints . Briefly, gold NPs were found to enter the cell in a concentration dependent manner  but did not induce oxidative stress nor a pro-inflammatory response. In addition, no synergistic or suppressive effects of the gold NPs could be observed, when simulating an inflammatory environment by LPS. The Ag-NP distribution was homogenous as observed for the gold NPs, however, imaging with TEM revealed a higher agglomeration state inside cellular vesicles for Ag-NPs than for gold NPs. In contrast to gold NP uptake no single Ag-NPs could be detected inside cells. These results were not quantitative as it is assumed that Ag-NPs can also dissolve inside cells.
Ag-NPs did not induce any cytotoxic reactions as could be observed for gold NPs too. The secretion of pro-inflammatory markers did not alter when measured by ELISA and transcriptional induction of pro-inflammatory and oxidative stress markers could not be observed. Furthermore, RT-PCR results confirm the ELISA experiments, as Ag-NPs do not alter the expression of TNF-α and IL-8 under inflammatory conditions.
There is an on-going debate whether Ag-NPs themselves or the ions released from the NPs are responsible for the observed effects . Therefore, we compared the effects when cells were exposed to Ag-NPs and Ag-ions at the same molecular mass by using a sophisticated application. The current study employed the ALICE system to nebulize a defined water-based solution onto cells. Previously, using the ALICE system Lenz et al. compared submerged and air-liquid interface exposures for zinc oxide NPs . The authors found with dose-response measurements significant differences in mRNA expression of pro-inflammatory (IL-8) and oxidative stress (HMOX-1) markers. Furthermore, Raemy et al. compared aerosol and suspension exposures and found that both exposure strategies differ fundamentally in their dose-response pattern . Both studies emphasize that interactions of NPs with cells depend on the exposure method. Therefore, a direct comparison of the related effects of either NPs or ions negates the problem that ions can be released from the NPs when in suspension, such as in submerged cultures. Thus, AgNO3 solutions with the same silver amount as the Ag-NP suspensions were prepared to directly compare particle related to ionic effects at the air-liquid interface. For the 0.22 and 2.2 mM AgNO3 concentrations, which contained the same total amount of silver as the Ag-NP suspensions for nebulization, similar results were observed as for the particle exposures. In contrast to Ag-NP exposures minor differences in response to oxidative stress could be observed. However, only when the AgNO3 concentration was increased to 22 mM, which was not possible to prepare for Ag-NP suspensions and also would represent an unrealistic high dose, differences in the expression pattern of analysed markers with RT-PCR could be monitored. A pro-inflammatory reaction upon exposure to this high ion concentration could be detected. Moreover, the expression of the pro-inflammatory marker IL-8 was significantly increased under inflammatory conditions, leading to an aggravating effect in combination with LPS treatment at 4 h after exposure. A direct interaction of LPS and Ag can be excluded since they have been added in different compartments, i.e. LPS was added in the lower well of the two chamber systems and the particles were nebulized on the cells on the upper side of the insert. If there is an interaction within the cells cannot be answered so far. Furthermore, a strong response to oxidative stress could be directly linked to the high concentration of Ag-ions. Also LDH measurements and LSM revealed that cell integrity is impaired only with the highest silver ion concentration. However, the LDH activity measured might be biased due to enzyme inhibition by silver and low cytotoxic levels could therefore be misinterpreted. Since we could not detect impaired cell morphology by LSM and TEM we had no evidence that the LDH test was affected with lower concentrations. In addition, the observed differences to Ag-NPs and Ag-ion concentrations were short-term and reversible within 24 h. This shows a strong influence of the ionic content of the exposed solution as well as a highly concentration dependent manner of inflammatory response to silver.
Many studies have shown that the toxicity of nano-Ag exposed to cells or animals can be related to the size, the shape, the ion content and the concentration, but the findings are highly controversial. On one hand in vivo  and in vitro [18, 19] analysis revealed only minor cytotoxic and inflammatory effects after silver exposure. Furthermore, just recently the authors of a study investigating the effects of Ag NPs at the air-liquid interface found only a negligible cytotoxic and minor inflammatory response . On the other hand Ag-NP toxicity was reported by many others whereas ROS dependent DNA damage, anti-proliferative effects, increase of inflammatory markers and subsequent cytotoxicity was observed in vitro [15, 17, 19, 20, 27, 47] and in vivo [35, 48, 49]. However, the mentioned studies do not allow a clear proposition if the observed effects are particle related or due to the ionic contribution as recently has been investigated . Moreover, any cellular reactions upon Ag-NP exposures might not only be related to the dose but also relevant to the exposed cell type . A differentiation of the mechanism of action under submerged conditions in vitro and of cellular effects in vivo stays difficult. Furthermore, dissolution of the Ag-NP in the aqueous lining layer and inside cells needs further investigations.
Ag-ions have a greater tendency to strongly interact with thiol groups of vital enzymes and phosphorus-containing bases . Because Ag-NPs have been found attached to the membrane of and internalised in bacteria [5, 18], these findings suggest that the antibacterial effect is related to the interaction of Ag with the respiratory chain enzymes, which are directly located at the outer membrane of bacteria and an increase in cell permeability due to a structural changes of the membrane. Also Ag induces free radicals and leads therefore subsequently to membrane and DNA damage [51, 52] (for a review see ). As shown in our study in response to an increasing dose of AgNO3 HMOX-1 is upregulated as an answer to oxidative stress and at the highest concentration can lead to cell damage. Therefore, our results suggest concentration related effects, whereas Ag-ions have immediate access to the cells and can interact with a wide variety of molecules. On the other hand when Ag-NPs, which are applied to the air-liquid interface of the cultured lung cells as monodisperse particles, come in contact with the cells they start to highly aggregate inside endocytotic vesicles as TEM pictures revealed. However, if aggregation already occurs in the aqueous hypophase or inside the vesicles cannot be shown. In addition it is also not possible to show if in the aqueous hypophase or inside the cells ions are released from the Ag-NPs as due to the low pH in endosomes and lysosomes the acidic environment is expected to induce Ag-NP dissolution.
Based on realistic exposure scenarios for silver and titanium, Gangwal et al.  recently calculated and recommended the concentrations of NPs used for in vitro assays. They found that an exposure scenario of a conservative concentration of 1 mg/m3 Ag results in a deposition of 0.061 - 0.15 μg/cm2 for 5 - 100 nm particles on the lung surface. Our concentrations with 0.03 and 0.27 μg/cm2 represent a realistic scenario for short-term exposures. Even a 10 times higher Ag-ion solution resulting in a calculated deposition of 3 μg/cm2 was used to observe effects at unrealistic high dose. Also most of the published studies look at short-term effects as pro-inflammatory, oxidative stress and proliferation markers, as well as DNA-damage over a short period of time, i.e. 24 to 48 h, but the applied concentrations represent lifetime exposure doses they apply at once. Therefore, Ag is added in a single exposure at unrealistic high dose and any observed effect does not necessarily represent realistic events when deposited particles accumulate over time. Also our results reveal that at a post-exposure time of 24 h all markers are decreased again to a basic level, which suggests only short-term effects of Ag. However, further studies are necessary to investigate the interference with biological processes for a chronic exposure scenario as Ag-NPs might continuously release Ag-ions. Ag-NPs cannot be rapidly cleared from the biological system in contrast to Ag-ions and therefore might lead to secondary effects over time.
Not only a realistic dose of NPs but also different cell types such as epithelial cells and immune cells have to be used. Co-culture models are better at simulating the real situation in the lung, than monocultures [53–57]. This is particularly important for toxicological studies including oxidative stress and pro-inflammatory reactions in lung cell culture models upon NP exposure. LDH release could only be observed for the highest Ag-ion concentration in A549 monocultures stimulated with LPS in contrary to the triple cell co-cultures. We could also show that there is no IL-8 release in A549 monocultures upon exposure to LPS since these cells do not express the receptor for this endotoxin. These findings point out the importance to include immune cells if risk assessment of NPs is performed.
By applying a realistic dose of Ag-NPs at the air-liquid interface of a human epithelial alveolar barrier model no significant cytotoxicity, release and induction of pro-inflammatory mediators was observed. The Ag-NPs were endocytosed and highly aggregated inside vesicular structures but they did not cause cytotoxicity, nor induce the release and expression of oxidative stress and pro-inflammatory markers. For equal AgNO3 exposure concentrations similar effects were observed. Furthermore, Ag-NPs as well as Ag-ions did not influence expression and release of pro-inflammatory and oxidative stress markers under inflammatory conditions. Only when the concentration of AgNO3 was further increased, the exposures did induce the (temporarily) expression of pro-inflammatory and oxidative stress markers revealing a concentration dependent effect. Our results indicate no acute cytotoxic and pro-inflammatory effects for Ag at a realistic exposure dose. Chronic exposure scenarios, however, might reveal other effects due to a prolonged exposure time. As the mammalian cell is complex, the scientific data revealed by many studies is controversial and there is an urgent need for realistic exposure systems as we used in the present study.
Experiments were carried out with a triple cell co-culture model of the human epithelial airway barrier as described in detail by [39, 58, 59]. Briefly, A549 cells were cultivated in Roswell Park Memorial Institute (RPMI) 1640 medium (w/25 mM HEPES, w/o L-Glutamine, Gibco, Life Technologies Europe B.V., Zug, Switzerland), supplemented with 1% penicillin G/streptomycin sulphate (P/S; 10,000 units/mL/10,000 μg/mL, Gibco), 1% L-Glutamine (L-Glut; Life Technologies Europe) and 10% foetal bovine serum (FBS; PAA Laboratories, Chemie Brunschwig AG, Basel, Switzerland), subsequently referred to as “RPMI complete medium”. For exposure experiments, cells were seeded in BD Falcon™ cell culture inserts (high pore density PET membranes with a growth area of 4.2 cm2 and 3.0 μm pores in diameter; Becton Dickinson AG, Allschwil, Switzerland) placed in BD Falcon™ 6-well tissue culture plates (Becton Dickinson) at a density of 0.5 × 106 cells/mL per insert. Cells were grown to confluence for 5 days under submerged conditions (2 mL RPMI complete medium in the upper and 3 mL in the lower transwell chamber). Peripheral blood monocytes were isolated from buffy coats (Blood donation service SRK Bern AG, Switzerland) and cultured in RPMI 1640 supplemented with 5% human serum (HS; Blood donation service), 1% P/S and 1% L-Glut, referred to as “isolation medium”. For the generation of monocyte-derived dendritic cells (MDDCs), the monocytes were cultured for 7 d in isolation medium with additional supplementation of 34 ng/mL IL-4 (R&D Systems Europe Ltd., Abingdon, UK) and 50 ng/mL GM-CSF (R&D Systems), whereas the monocyte-derived macrophages (MDMs) were obtained without any additional supplements for 7 d.
The triple cell co-cultures were set together as described in detail  by adding 500 μL of a MDM suspension to the apical and 300 μL of a MDDC suspension to the basal side of the insert. After cultivation for 24 h in the incubator the cells were transferred from submerged to air-liquid interface conditions. The cell culture medium from the upper transwell chamber was removed and the cell culture medium in the lower transwell chamber was replaced by 1.2 mL of fresh isolation medium. After additional 24 h in the incubator at the air-liquid interface, the co-cultures were ready for exposure. In some of the experiments, an inflammatory environment was created by adding 1 μg/mL lipopolysaccharide (LPS) (Pseudomonas aeruginosa, Sigma Aldrich Chemie GmbH, Buchs, Switzerland) into the medium of the lower transwell chamber 2 h before Ag-NP or AgNO3 exposure .
Cells were exposed to nanoparticles using the air-liquid interface cell exposure system (ALICE) as previously described by [40, 41]. Briefly, the ALICE consists of four main components: a droplet generator (nebulizer), an exposure chamber, a flow system with an incubation chamber providing temperature and humidity conditions suitable for cell cultivation and a quartz crystal microbalance (QCM; Stanford Research Systems, GMP SA, Renens, Switzerland) for real-time measurement of the cell-delivered NP dose. A dense cloud of micron-sized droplets is generated by nebulization of 1 mL Ag-NP suspension using a vibrating membrane droplet generator (investigational eFlow, PARI Pharma GmbH, Munich, Germany). The dense cloud of droplets generated by the eFlow nebulizer is transported at a flow rate of 5 L/min into the exposure chamber (20 × 20 × 30 cm) where it gently deposits onto cells cultured at the air-liquid interface in standard cell culture plates. Droplet deposition occurs due to single particle sedimentation and an effect known as cloud settling, i.e. the cloud of droplets moves like a bulk object rather than a collection of individual droplets . The flow rate is chosen so that the cloud is diverted to all sides by the ground plate of the exposure chamber to form an almost symmetric pattern of vortices providing gentle but sufficient mixing to result in uniform special droplet deposition on the cells. Following the exposure, taking about 15 min, the cells were kept under air-liquid interface conditions for post-exposure incubation times of 4 and 24 h in 5% CO2 humidified atmosphere at 37°C.
Commercially available 20 nm citrate-coated colloidal Ag-NPs suspended in H2O from British Biocell International (EM.SC20; Plano GmbH, Wetzlar, Germany) were used. Measurements by ICP-MS revealed that the NP suspension had a nominal concentration of 0.0006% silver, corresponding to a silver mass concentration of 6 μg/mL. A 4- and 40-fold concentration of colloidal silver nanoparticles was achieved by ultrafiltration using 30 kDa MWCO centrifugal filter units (Vivaspin 20; Sartorius Stedim AG, Tagelswangen, Switzerland) at 3000 × g by diafiltration for 10 min. The Ag-NP solutions were always freshly prepared by ultrafiltration before exposure.
The size distribution and zeta potential of the Ag-NP stock solutions were analysed by dynamic light scattering (Zetasizer Nano Series, Malvern Instruments Ltd., Worcestershire, UK and 90plus Particle Size Analyser with BI-ZTU Autotitrator, Brookhaven Instruments Corp., Holtsville, USA). Images from transmission electron microscopy (TEM) grids exposed to particles in the ALICE during experiments were taken by TEM (Philips CM12, FEI Co. Philips Electron Optics, Zurich, Switzerland) and further analysed by ImageJ particle analyser.
Analysis of dissolved silver was performed by ultrafiltration using Ultracel 3 k Centrifugal Filter Devices (Amicon; Millipore, Zug, Switzerland) with a MWCO of 3 kDa (pore size < 2 nm) as described by . The filtrates were acidified and the total Ag concentration (isotope 109Ag) was measured by ICP-MS (Element 2 High Resolution Sector Field ICP-MS; Thermo Finnigan AG, Allschwil, Switzerland).
The silver mass deposited on the cells was determined by ICP-MS as described by . Briefly, exposed silver NPs were collected in 1 mL ddH2O placed in empty 6-wells of tissue culture plates. The total Ag concentration (isotope 109Ag) in the silver NP suspensions was measured by ICP-MS after digestion with 4 mL of 65% HNO3 and 1 mL of 30% H2O2 in a high-performance microwave digestion unit (MLS 1200 mega, MLS GmbH, Leutkirch, Germany) at a maximal temperature of 195°C. The reliability of the measurements was determined using specific water references (National Water Research Institute, Burlington, Canada). The recovery for silver NPs was 94.7 ± 4.8%.
Real-time reverse-transcriptase polymerase chain reaction (real-time RT-PCR)
Following post-incubation of Ag-NP and AgNO3 exposures for 4 h and 24 h, the insert membranes were cut out, transferred immediately into RNAprotect cell reagent (Qiagen AG, Hombrechtikon, Switzerland) and stored at 4°C until further processing. Cells were detached by vortexing and lysed by centrifuging with QIAshredder columns (Qiagen). Total RNA was isolated using the RNeasy plus kit (Qiagen) according to the manufacturer’s guidelines and RNA concentration was determined by a NanoDrop 2000 (Thermo Scientific, Witec AG, Littau, Switzerland). Reverse transcription (incubation 1 h at 37°C) was carried out with the Omniscript Reverse Transcription Kit (Qiagen) in 10 μL volume with 0.25 μg RNA/reaction, using a master mix consisting of 0.25 mM of each dNTP (Qiagen), 0.5 μM Oligo-dT primers (Qiagen), 10 units RNase inhibitor (RNasin Plus RNase Inhibitor, Promega AG, Dübendorf, Switzerland), 2 units Omniscript Reverse Transcriptase (Qiagen) and 1x buffer RT (Qiagen). Real-time PCR was performed in a reaction volume of 10 μL, with a total of 2 μL of tenfold diluted cDNA, using a Fast SYBR Green master mix (Applied Biosystems, Life Technologies Europe B.V., Zug, Switzerland) with a 50 nM primer mix in a 7500 Fast real-time PCR system (Applied Biosystems). Settings: Denature 20 sec at 95°C, PCR Cycles (40): 3 sec at 95°C, 30 sec at 60°C. Relative expression levels were calculated using the ΔΔCt method as described elsewhere  with glyceraldehyde-3-phosphate reductase (GAPDH) [GenBank: NC_000012] as internal reference gene. The expression levels of heme-oxygenase 1 (HMOX-1) [GenBank: CP002685], superoxide dismutase 1 (SOD-1) [GenBank: NM_000454], interleukin-8 (IL-8) [GenBank: NM_000584] and tumour necrosis factor-α (TNF-α) [GenBank: NM_000594] were determined. Primer sequences (Microsynth AG, Balgach, Switzerland) were the following: GAPDH: forward 5’- AAC AGC CTC AAG ATC ATC AGC-3’, reverse 5’- GGA TGA TGT TCT GGA GAG CC-3’; HMOX-1: forward 5’- TTC TCC GAT GGG TCC TTA CAC T-3’, reverse 5’- GGC ATA AAG CCC TAC AGC AAC T-3’; SOD-1: forward 5’- GTG CAG GTC CTC ACT TTA AT-3’, reverse 5’- CTT TGT CAG CAG TCA CAT TG-3’; IL-8: forward 5’- CTG GCC GTG GCT CTC TTG-3’, reverse 5’- CCT TGG CAA AAC TGC ACC TT-3’; TNF-α: forward 5’- CCC AGG GAC CTC TCT CTA ATC A -3’, reverse 5’- GCT ACA GGC TTG TCA CTC GG -3’.
Lactate dehydrogenase release
As a general measure for cytotoxicity, the release of lactate dehydrogenase (LDH) from destroyed cells was assessed. For that, the medium of the lower transwell was collected 4 h and 24 h after exposure and stored at 4°C for analysis. The LDH cytotoxicity detection kit (Roche Applied Science, Mannheim, Germany) was used according to the supplier’s manual. LDH was quantified photometrically by measuring at 490 nm, with 630 nm as reference wavelength. Each sample was assessed in triplicate. The values were expressed as fold increase related to the incubator control at appropriate post-exposure times. For positive controls co-cultures were exposed to 0.2% Triton X-100 detergent in H2O at 37°C for the same duration as samples were post-incubated.
Chemokine / Cytokine quantification
Protein release of pro-inflammatory mediators IL-8 and TNF-α were quantified by a commercially available DuoSet ELISA Development Kit (R&D Systems) according to the manufacturer’s protocol. LPS (1 μg/mL) and TNF-α (15 ng/mL; Sigma-Aldrich) served as positive control for TNF-α and IL-8 induction respectively.
Laser scanning microscopy
The triple cell co-cultures were fixed on the cell culture insert with 3% paraformaldehyde in phosphate buffered saline (PBS) for 15 min at room temperature and then treated with 0.1 M glycine in PBS for 10 min. Before staining, the cells were permeabilised with 0.2% Triton X-100 in PBS for 15 min at room temperature. The cytoskeleton i.e. actin-filaments of all cells were stained with rhodamine phalloidin 1:100 (R-415; Molecular Probes, Life Technologies Europe B.V., Zug, Switzerland) and DNA was stained with DAPI 1 μg/mL (Sigma Aldrich). Preparations for optical analysis were mounted in Glycergel (DAKO Schweiz AG, Baar, Switzerland). The samples were visualized with an inverted Zeiss laser-scanning microscope (LSM) 710 (Axio Observer.Z1, Lasers: HeNe 633 nm, and Ar 488 nm). Image processing was performed with the 3D multi-channel image processing software IMARIS (Bitplane AG, Zurich, Switzerland). Samples with no fluorescence labelling were used to adjust the background parameters for the stained cells in order to avoid unspecific signals from the Ag-NPs or ions (see Additional file 3).
Transmission electron microscopy
Intracellular particles were visualized by conventional transmission electron microscopy (TEM). For TEM analysis, the exposed cells on the transwell membrane were fixed with 2.5% glutaraldehyde in 0.03 M potassium phosphate buffer for at least 24 h, subsequently washed with potassium phosphate buffer and post-fixed with 1% osmium tetroxide in sodium cacodylate buffer, washed with maleate buffer, and stained en bloc with 0.5% uranyl acetate in maleate buffer. Afterwards, the cells were dehydrated in ascending ethanol series, and embedded in epon . From the embedded cells, ultrathin sections were cut parallel to the vertical axis of the inserts, mounted on copper grids and stained with uranyl acetate. Imaging was done with a Philips CM12 TEM (FEI Co Philips Electron Optics).
All data are presented as the mean ± standard error of the mean (SEM). Statistical analysis was performed with GraphPad Prism 5 (GraphPad Software Inc., La Jolla, California, USA). A two-way analysis of variance (ANOVA) with a subsequent Bonferroni post-hoc test was performed. Values were considered significantly different with p < 0.05 (*), p < 0.01 (**), p < 0.001 (***) or p < 0.0001 (****).
The authors would like to thank Beat Kistler for helping with the ICP-MS measurements, as well as the group of Prof. Wolfgang Parak for their scientific support. Furthermore, the authors would like to thank Yuki Umehara for her technical support and Christina Brandenberger for her scientific assistance. This work was financed by the Federal Office of Public Health, Switzerland, the Swiss National Science Foundation, The National Research Program 64, and the Adolphe Merkle Foundation.
- The European Commission: Commission Recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU). Brussels, Official Journal of the European Union 2011., L 275/38:
- Luxresearch Inc: Nanomaterials State of the Market Q3 2008: stealth success, broad impact. St Market Rep 2008. https://portal.luxresearchinc.com/research/document_excerpt/3735
- Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H: Toxicity of silver nanoparticles - nanoparticle or silver ion? Toxicol Lett 2012, 208: 286–292. 10.1016/j.toxlet.2011.11.002View ArticlePubMed
- Edwards-Jones V: The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 2009, 49: 147–152. 10.1111/j.1472-765X.2009.02648.xView ArticlePubMed
- Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ: The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16: 2346. 10.1088/0957-4484/16/10/059View ArticlePubMed
- Klasen HJ: Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000, 26: 117–130. 10.1016/S0305-4179(99)00108-4View ArticlePubMed
- Rai M, Yadav A, Gade A: Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27: 76–83. 10.1016/j.biotechadv.2008.09.002View ArticlePubMed
- Hagen Mikkelsen S, Hansen E, Christensen TB, Baun A, Foss Hansen S, Binderup M-L: Survey on basic knowledge about exposure and potential environmental and health risks for selected nanomaterials. Miljøprojekt 2011, 1–136. Environmental Project No. 1370 2011
- Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113: 823–839. 10.1289/ehp.7339PubMed CentralView ArticlePubMed
- Oberdorster G, Stone V, Donaldson K: Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1: 2–25. 10.1080/17435390701314761View Article
- Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van de Meent D: Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3: 109-U178. 10.1080/17435390902725914View Article
- Ahamed M, Alsalhi MS, Siddiqui MK: Silver nanoparticle applications and human health. Clin Chim Acta 2010, 411: 1841–1848. 10.1016/j.cca.2010.08.016View ArticlePubMed
- Gangwal S, Brown JS, Wang A, Houck KA, Dix DJ, Kavlock RJ, Hubal EA: Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ Health Persp 2011, 119: 1539–1546. 10.1289/ehp.1103750View Article
- Park EJ, Yi J, Kim Y, Choi K, Park K: Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 2010, 24: 872–878. 10.1016/j.tiv.2009.12.001View ArticlePubMed
- Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H: PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190: 156–162. 10.1016/j.toxlet.2009.07.009View ArticlePubMed
- Shin SH, Ye MK, Kim HS, Kang HS: The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 2007, 7: 1813–1818. 10.1016/j.intimp.2007.08.025View ArticlePubMed
- Foldbjerg R, Dang DA, Autrup H: Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011, 85: 743–750. 10.1007/s00204-010-0545-5View ArticlePubMed
- Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH: Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 2007, 19 Suppl 1: 59–65.View ArticlePubMed
- Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P: Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 2009, 6: 14. 10.1186/1743-8977-6-14PubMed CentralView ArticlePubMed
- AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S: Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3: 279–290. 10.1021/nn800596wView ArticlePubMed
- Kawata K, Osawa M, Okabe S: In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 2009, 43: 6046–6051. 10.1021/es900754qView ArticlePubMed
- Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong YL: DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharm 2008, 233: 404–410. 10.1016/j.taap.2008.09.015View Article
- Lubick N: Nanosilver toxicity: ions, nanoparticles–or both? Environ Sci Technol 2008, 42: 8617. 10.1021/es8026314View ArticlePubMed
- Yang X, Gondikas AP, Marinakos SM, Auffan M, Liu J, Hsu-Kim H, Meyer JN: Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans. Environ Sci Technol 2012, 46: 1119–1127. 10.1021/es202417tView ArticlePubMed
- Liu J, Hurt RH: Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 2010, 44: 2169–2175. 10.1021/es9035557View ArticlePubMed
- Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ: Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 2012, 12: 4271–4275. 10.1021/nl301934wView ArticlePubMed
- Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ: Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112: 13608–13619. 10.1021/jp712087mView ArticlePubMed
- Stoehr LC, Gonzalez E, Stampfl A, Casals E, Duschl A, Puntes V, Oostingh GJ: Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol 2011, 8: 36. 10.1186/1743-8977-8-36PubMed CentralView ArticlePubMed
- Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY: Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 2009, 23: 1076–1084. 10.1016/j.tiv.2009.06.001View ArticlePubMed
- Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R: Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 2008, 42: 8959–8964. 10.1021/es801785mView ArticlePubMed
- Fabrega J, Luoma SN, Tyler CR, Galloway TS, Lead JR: Silver nanoparticles: behaviour and effects in the aquatic environment. Environ Int 2011, 37: 517–531. 10.1016/j.envint.2010.10.012View ArticlePubMed
- Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briede JJ, van Loveren H, de Jong WH: The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011, 32: 9810–9817. 10.1016/j.biomaterials.2011.08.085View ArticlePubMed
- Sur I, Cam D, Kahraman M, Baysal A, Culha M: Interaction of multi-functional silver nanoparticles with living cells. Nanotechnology 2010, 21: 175104. 10.1088/0957-4484/21/17/175104View ArticlePubMed
- Asharani PV, Hande MP, Valiyaveettil S: Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 2009, 10: 65. 10.1186/1471-2121-10-65PubMed CentralView ArticlePubMed
- Park EJ, Choi K, Park K: Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice. Arch Pharm Res 2011, 34: 299–307. 10.1007/s12272-011-0216-yView ArticlePubMed
- Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS: Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 2011, 8: 5. 10.1186/1743-8977-8-5PubMed CentralView ArticlePubMed
- Perkel JM: LIFE SCIENCE TECHNOLOGIES: animal-free toxicology: sometimes, in vitro is better. Science 2012, 335: 1122–1125. 10.1126/science.335.6072.1122View Article
- Rothen-Rutishauser B, Mueller L, Blank F, Brandenberger C, Muehlfeld C, Gehr P: A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX 2008, 25: 191–196.PubMed
- Blank F, Rothen-Rutishauser B, Gehr P: Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 2007, 36: 669–677. 10.1165/rcmb.2006-0234OCView ArticlePubMed
- Lenz AG, Karg E, Lentner B, Dittrich V, Brandenberger C, Rothen-Rutishauser B, Schulz H, Ferron GA, Schmid O: A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Part Fibre Toxicol 2009, 6: 32. 10.1186/1743-8977-6-32PubMed CentralView ArticlePubMed
- Brandenberger C, Rothen-Rutishauser B, Muhlfeld C, Schmid O, Ferron GA, Maier KL, Gehr P, Lenz AG: Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 2010, 242: 56–65. 10.1016/j.taap.2009.09.014View ArticlePubMed
- Brandenberger C, Muhlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, Gehr P, Rothen-Rutishauser B: Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 2010, 6: 1669–1678. 10.1002/smll.201000528View ArticlePubMed
- Brandenberger C, Clift MJ, Vanhecke D, Muhlfeld C, Stone V, Gehr P, Rothen-Rutishauser B: Intracellular imaging of nanoparticles: is it an elemental mistake to believe what you see? Part Fibre Toxicol 2010, 7: 15. 10.1186/1743-8977-7-15PubMed CentralView ArticlePubMed
- Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3: 1101–1108. 10.1038/nprot.2008.73View ArticlePubMed
- Raemy DO, Grass RN, Stark WJ, Schumacher CM, Clift MJ, Gehr P, Rothen Rutishauser B: Effects of flame made zinc oxide particles in human lung cells - a comparison of aerosol and suspension exposures. Part Fibre Toxicol 2012, 9: 33. 10.1186/1743-8977-9-33PubMed CentralView ArticlePubMed
- Holder AL, Marr LC: Toxicity of silver nanoparticles at the air-liquid interface. BioMed research international 2013, 2013: 328934.PubMed CentralView ArticlePubMed
- Lim D, Roh JY, Eom HJ, Choi JY, Hyun J, Choi J: Oxidative stress-related PMK-1 P38 MAPK activation as a mechanism for toxicity of silver nanoparticles to reproduction in the nematode Caenorhabditis elegans. Environ Toxicol Chem 2012, 31: 585–592. 10.1002/etc.1706View ArticlePubMed
- Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J: Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 2008, 20: 567–574. 10.1080/08958370701874671View ArticlePubMed
- Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH: Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 2009, 108: 452–461. 10.1093/toxsci/kfn246View ArticlePubMed
- Hatchett DW, White HS: Electrochemistry of sulfur adlayers on the low-index faces of silver. J Phys Chem 1996, 100: 9854–9859. 10.1021/jp953757zView Article
- Danilczuk M, Lund A, Sadlo J, Yamada H, Michalik J: Conduction electron spin resonance of small silver particles. Spectrochim Acta A Mol Biomol Spectrosc 2006, 63: 189–191. 10.1016/j.saa.2005.05.002View ArticlePubMed
- Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY: Antimicrobial effects of silver nanoparticles. Nanomedicine 2007, 3: 95–101. 10.1016/j.nano.2006.12.001View ArticlePubMed
- Muller L, Riediker M, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B: Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J R Soc Interface 2010,7(Suppl 1):S27-S40.PubMed CentralView ArticlePubMed
- Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P: In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 2008, 4: 1075–1089. 10.1517/17425255.4.8.1075View ArticlePubMed
- Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, Gehr P, Krug HF, Rothen-Rutishauser B: Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro. Part Fibre Toxicol 2012, 9: 17. 10.1186/1743-8977-9-17PubMed CentralView ArticlePubMed
- Clift MJ, Foster EJ, Vanhecke D, Studer D, Wick P, Gehr P, Rothen-Rutishauser B, Weder C: Investigating the interaction of cellulose nanofibers derived from cotton with a sophisticated 3D human lung cell coculture. Biomacromolecules 2011, 12: 3666–3673. 10.1021/bm200865jView ArticlePubMed
- Lehmann AD, Parak WJ, Zhang F, Ali Z, Rocker C, Nienhaus GU, Gehr P, Rothen-Rutishauser B: Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small 2010, 6: 753–762. 10.1002/smll.200901770View ArticlePubMed
- Rothen-Rutishauser BM, Kiama SG, Gehr P: A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 2005, 32: 281–289. 10.1165/rcmb.2004-0187OCView ArticlePubMed
- Blank F, Rothen-Rutishauser BM, Schurch S, Gehr P: An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 2006, 19: 392–405. 10.1089/jam.2006.19.392View ArticlePubMed
- Lehmann A, Brandenberger C, Blank F, Gehr P, Rothen-Rutishauser B: A 3D model of the human epithelial airway barrier. In Methods in bioengineering: alternative technologies to animal testing. Edited by: ML Y, RS L. Artech House: Boston, Mass; 2010:239–260.
- Muhlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M: Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol 2007, 4: 11. 10.1186/1743-8977-4-11PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.